Study Details

Back
Study ID 7487-CL-0104
Study Title A Phase 1, Open-label Study to Investigate the Absorption, Metabolism, and Excretion of 14C-OSI-906 in Subjects with Advanced Solid Tumors with an Optional Treatment Phase
Clinicaltrials.gov Identifier NCT01529684
Compound Name ASP7487 / OSI-906 / linsitinib
Medical Indication or Disease Solid tumors
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 19-Mar-2012
Study Completion Date 20-Feb-2013
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS